Skip to main content
. Author manuscript; available in PMC: 2014 Jan 8.
Published in final edited form as: Genet Med. 2013 Jun 27;16(1):10.1038/gim.2013.80. doi: 10.1038/gim.2013.80

Figure 1. Predicted risks by 23andMe, deCODEme, and Navigenics for six multifactorial diseases.

Figure 1

The figure shows the predicted risks for a hypothetical population of 100,000 individuals (see Materials and Methods section). The solid line indicates when predicted risks by deCODEme or Navigenics are the same as predicted risks by 23andMe. Mote than the ranges of the axes differ among the companies. AMD, age-related macular degeneration.